2023-2027年全球智慧吸入器市場

預計2022-2027年智慧吸入器市場將成長4,637萬美元，預測期內年複合成長率為10.16%。

該報告包括對智慧吸入器市場的總體分析、市場規模/預測、趨勢、成長促進因素、課題以及涵蓋約 25 家供應商的供應商分析。

本報告提供對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括呼吸系統疾病患病上升、對互聯醫療系統的需求不斷增加以及醫療保健支出增加。

研究指出，即時回饋的可能性是未來年度推動智慧吸入器市場成長的關鍵要素之一。此外，醫療保健數位化的不斷發展和技術進步的不斷進步將促使市場的巨大需求。

目錄

第1章 執行摘要

• 市場概況

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 區隔市場分析
• 2022 年市場規模
• 2022-2027年市場預測

第4章 市場規模實績

• 2017-2021年全球智慧吸入器市場
• 2017-2021 年依產品區隔分析
• 2017-2021 年依用途分類的區隔市場分析
• 2017-2021 年區域區隔分析
• 2017-2021 年國家區隔分析

第5章 五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代的威脅
• 競爭威脅
• 市場狀況

第6章 市場區隔：依產品

• 區隔市場
• 比較：依產品
• 吸入器：2022-2027 年市場規模與預測
• 霧化器：2022-2027年市場規模與預測
• 市場機會：依產品

第7章 市場區隔：依用途

• 區隔市場
• 比較：依用途
• 氣喘：2022-2027 年市場規模與預測
• 慢性阻塞性肺病：2022-2027 年市場規模與預測
• 市場機會：依用途

第8章 客戶形勢

• 客戶形勢概覽

第9章 地區形勢

• 區域區隔
• 區域比較
• 北美：2022-2027 年市場規模與預測
• 歐洲：2022-2027 年市場規模與預測
• 亞洲：2022-2027 年市場規模與預測
• 世界其他地區：2022-2027 年市場規模與預測
• 美國：2022-2027 年市場規模與預測
• 英國：2022-2027 年市場規模與預測
• 法國：2022-2027年市場規模與預測
• 中國：2022-2027年市場規模及預測
• 日本：2022-2027 年市場規模與預測
• 市場機會：依地區形勢

第10章 促進因素、課題與趨勢

• 市場促進因素
• 市場課題
• 促進因素和課題的影響
• 市場趨勢

第11章供應商形勢

• 概述
• 供應商形勢
• 混亂的情況
• 產業風險

第12章供應商分析

• 交易廠商
• 供應商市場定位
• 3M Co.
• Adherium Ltd.
• Amiko Digital Health Ltd.
• AptarGroup Inc.
• AstraZeneca Plc
• Cognita Labs
• Cohero Health Inc.
• Findair Sp. z oo
• Infineon Technologies AG
• Novartis AG
• OPKO Health Inc.
• ResMed Inc.
• Sensirion AG
• Teva Pharmaceutical Industries Ltd.
• Vectura Group plc

第13章附錄

The smart inhaler technology market is forecasted to grow by USD 46.37 mn during 2022-2027, accelerating at a CAGR of 10.16% during the forecast period. The report on the smart inhaler technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of respiratory diseases, growing demand for connected healthcare systems, and increasing healthcare expenditure.

Technavio's smart inhaler technology market is segmented as below:

By Product

• Inhalers
• Nebulizers

By Application

• Asthma
• COPD

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the availability of real-time feedback as one of the prime reasons driving the smart inhaler technology market growth during the next few years. Also, growing healthcare digitalization and rising technological advancements will lead to sizable demand in the market.

The report on the smart inhaler technology market covers the following areas:

• Smart inhaler technology market sizing
• Smart inhaler technology market forecast
• Smart inhaler technology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smart inhaler technology market vendors that include 3M Co., Adherium Ltd., Amiko Digital Health Ltd., AptarGroup Inc., AstraZeneca Plc, Cognita Labs, Cohero Health Inc., Findair Sp. z o. o., Infineon Technologies AG, Novartis AG, OPKO Health Inc., ResMed Inc., Sensirion AG, Teva Pharmaceutical Industries Ltd., and Vectura Group plc. Also, the smart inhaler technology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global smart inhaler technology market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global smart inhaler technology market 2017 - 2021 ($ million)
• 4.2 Product Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.3 Application Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Inhalers - Market size and forecast 2022-2027
• Exhibit 34: Chart on Inhalers - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Inhalers - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
• 6.4 Nebulizers - Market size and forecast 2022-2027
• Exhibit 38: Chart on Nebulizers - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Nebulizers - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Nebulizers - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Nebulizers - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Product
• Exhibit 42: Market opportunity by Product ($ million)
• Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 44: Chart on Application - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
• 7.2 Comparison by Application
• Exhibit 46: Chart on Comparison by Application
• Exhibit 47: Data Table on Comparison by Application
• 7.3 Asthma - Market size and forecast 2022-2027
• Exhibit 48: Chart on Asthma - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Asthma - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Asthma - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
• 7.4 COPD - Market size and forecast 2022-2027
• Exhibit 52: Chart on COPD - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on COPD - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on COPD - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on COPD - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Application
• Exhibit 56: Market opportunity by Application ($ million)
• Exhibit 57: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 83: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.9 France - Market size and forecast 2022-2027
• Exhibit 87: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on France - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ million)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 3M Co.
• Exhibit 107: 3M Co. - Overview
• Exhibit 108: 3M Co. - Business segments
• Exhibit 109: 3M Co. - Key news
• Exhibit 110: 3M Co. - Key offerings
• Exhibit 111: 3M Co. - Segment focus
• 12.4 Adherium Ltd.
• Exhibit 112: Adherium Ltd. - Overview
• Exhibit 113: Adherium Ltd. - Product / Service
• Exhibit 114: Adherium Ltd. - Key offerings
• 12.5 Amiko Digital Health Ltd.
• Exhibit 115: Amiko Digital Health Ltd. - Overview
• Exhibit 116: Amiko Digital Health Ltd. - Product / Service
• Exhibit 117: Amiko Digital Health Ltd. - Key offerings
• 12.6 AptarGroup Inc.
• Exhibit 118: AptarGroup Inc. - Overview
• Exhibit 119: AptarGroup Inc. - Business segments
• Exhibit 120: AptarGroup Inc. - Key offerings
• Exhibit 121: AptarGroup Inc. - Segment focus
• 12.7 AstraZeneca Plc
• Exhibit 122: AstraZeneca Plc - Overview
• Exhibit 123: AstraZeneca Plc - Product / Service
• Exhibit 124: AstraZeneca Plc - Key news
• Exhibit 125: AstraZeneca Plc - Key offerings
• 12.8 Cognita Labs
• Exhibit 126: Cognita Labs - Overview
• Exhibit 127: Cognita Labs - Product / Service
• Exhibit 128: Cognita Labs - Key offerings
• 12.9 Cohero Health Inc.
• Exhibit 129: Cohero Health Inc. - Overview
• Exhibit 130: Cohero Health Inc. - Product / Service
• Exhibit 131: Cohero Health Inc. - Key offerings
• 12.10 Findair Sp. z o. o.
• Exhibit 132: Findair Sp. z o. o. - Overview
• Exhibit 133: Findair Sp. z o. o. - Product / Service
• Exhibit 134: Findair Sp. z o. o. - Key offerings
• 12.11 Infineon Technologies AG
• Exhibit 135: Infineon Technologies AG - Overview
• Exhibit 136: Infineon Technologies AG - Business segments
• Exhibit 137: Infineon Technologies AG - Key news
• Exhibit 138: Infineon Technologies AG - Key offerings
• Exhibit 139: Infineon Technologies AG - Segment focus
• 12.12 Novartis AG
• Exhibit 140: Novartis AG - Overview
• Exhibit 141: Novartis AG - Business segments
• Exhibit 142: Novartis AG - Key offerings
• Exhibit 143: Novartis AG - Segment focus
• 12.13 OPKO Health Inc.
• Exhibit 144: OPKO Health Inc. - Overview
• Exhibit 145: OPKO Health Inc. - Business segments
• Exhibit 146: OPKO Health Inc. - Key offerings
• Exhibit 147: OPKO Health Inc. - Segment focus
• 12.14 ResMed Inc.
• Exhibit 148: ResMed Inc. - Overview
• Exhibit 149: ResMed Inc. - Business segments
• Exhibit 150: ResMed Inc. - Key news
• Exhibit 151: ResMed Inc. - Key offerings
• Exhibit 152: ResMed Inc. - Segment focus
• 12.15 Sensirion AG
• Exhibit 153: Sensirion AG - Overview
• Exhibit 154: Sensirion AG - Product / Service
• Exhibit 155: Sensirion AG - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Vectura Group plc
• Exhibit 161: Vectura Group plc - Overview
• Exhibit 162: Vectura Group plc - Product / Service
• Exhibit 163: Vectura Group plc - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 164: Inclusions checklist
• Exhibit 165: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 166: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 167: Research methodology
• Exhibit 168: Validation techniques employed for market sizing
• Exhibit 169: Information sources
• 13.5 List of abbreviations
• Exhibit 170: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global smart inhaler technology market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Product - Market share 2022-2027 (%)
• Exhibits31: Data Table on Product - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Inhalers - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Inhalers - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Nebulizers - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Nebulizers - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Nebulizers - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Nebulizers - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Product ($ million)
• Exhibits43: Data Table on Market opportunity by Product ($ million)
• Exhibits44: Chart on Application - Market share 2022-2027 (%)
• Exhibits45: Data Table on Application - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Application
• Exhibits47: Data Table on Comparison by Application
• Exhibits48: Chart on Asthma - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Asthma - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Asthma - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on COPD - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on COPD - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on COPD - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on COPD - Year-over-year growth 2022-2027 (%)
• Exhibits56: Market opportunity by Application ($ million)
• Exhibits57: Data Table on Market opportunity by Application ($ million)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on France - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits99: Market opportunity By Geographical Landscape ($ million)
• Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits101: Impact of drivers and challenges in 2022 and 2027
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: 3M Co. - Overview
• Exhibits108: 3M Co. - Business segments
• Exhibits109: 3M Co. - Key news
• Exhibits110: 3M Co. - Key offerings
• Exhibits111: 3M Co. - Segment focus
• Exhibits112: Adherium Ltd. - Overview
• Exhibits113: Adherium Ltd. - Product / Service
• Exhibits114: Adherium Ltd. - Key offerings
• Exhibits115: Amiko Digital Health Ltd. - Overview
• Exhibits116: Amiko Digital Health Ltd. - Product / Service
• Exhibits117: Amiko Digital Health Ltd. - Key offerings
• Exhibits118: AptarGroup Inc. - Overview
• Exhibits119: AptarGroup Inc. - Business segments
• Exhibits120: AptarGroup Inc. - Key offerings
• Exhibits121: AptarGroup Inc. - Segment focus
• Exhibits122: AstraZeneca Plc - Overview
• Exhibits123: AstraZeneca Plc - Product / Service
• Exhibits124: AstraZeneca Plc - Key news
• Exhibits125: AstraZeneca Plc - Key offerings
• Exhibits126: Cognita Labs - Overview
• Exhibits127: Cognita Labs - Product / Service
• Exhibits128: Cognita Labs - Key offerings
• Exhibits129: Cohero Health Inc. - Overview
• Exhibits130: Cohero Health Inc. - Product / Service
• Exhibits131: Cohero Health Inc. - Key offerings
• Exhibits132: Findair Sp. z o. o. - Overview
• Exhibits133: Findair Sp. z o. o. - Product / Service
• Exhibits134: Findair Sp. z o. o. - Key offerings
• Exhibits135: Infineon Technologies AG - Overview
• Exhibits136: Infineon Technologies AG - Business segments
• Exhibits137: Infineon Technologies AG - Key news
• Exhibits138: Infineon Technologies AG - Key offerings
• Exhibits139: Infineon Technologies AG - Segment focus
• Exhibits140: Novartis AG - Overview
• Exhibits141: Novartis AG - Business segments
• Exhibits142: Novartis AG - Key offerings
• Exhibits143: Novartis AG - Segment focus
• Exhibits144: OPKO Health Inc. - Overview
• Exhibits145: OPKO Health Inc. - Business segments
• Exhibits146: OPKO Health Inc. - Key offerings
• Exhibits147: OPKO Health Inc. - Segment focus
• Exhibits148: ResMed Inc. - Overview
• Exhibits149: ResMed Inc. - Business segments
• Exhibits150: ResMed Inc. - Key news
• Exhibits151: ResMed Inc. - Key offerings
• Exhibits152: ResMed Inc. - Segment focus
• Exhibits153: Sensirion AG - Overview
• Exhibits154: Sensirion AG - Product / Service
• Exhibits155: Sensirion AG - Key offerings
• Exhibits156: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits157: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits158: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits159: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits160: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits161: Vectura Group plc - Overview
• Exhibits162: Vectura Group plc - Product / Service
• Exhibits163: Vectura Group plc - Key offerings
• Exhibits164: Inclusions checklist
• Exhibits165: Exclusions checklist
• Exhibits166: Currency conversion rates for US$
• Exhibits167: Research methodology
• Exhibits168: Validation techniques employed for market sizing
• Exhibits169: Information sources
• Exhibits170: List of abbreviations